HEYER ANDREW R 4

What Happened Andrew R. Heyer, a director of biote Corp. (BTMD), received two equity awards reported on a Form 4 filed May 14, 2026 for transactions dated May 12, 2026. The grants consist of 35,259 Deferred Settlement RSUs and a 130,000-share option award. Both awards are reported as derivative acquisitions at $0.00 (typical for compensation grants); no shares were sold.

Key Details

• Transaction date: May 12, 2026; Form 4 filed May 14, 2026 (accession 0001259062-26-000002).
• Consideration/price: $0.00 for both awards (award/compensation grants, not market purchases).
• Award amounts: 35,259 Deferred Settlement RSUs; 130,000 shares subject to an option award.
• Shares owned after transaction: Not specified in the filing.
• Footnotes of note:
  • F1: Each Deferred Settlement RSU equals the economic equivalent of one share of Class A common stock.
  • F2: The Deferred Settlement RSUs are fully vested on grant, but settlement is deferred until the reporting person’s separation from service.
  • F3: The option award vests on the earlier of May 12, 2027 or the day before the issuer’s 2027 annual meeting, subject to continuous service.
• Timeliness: Filing shows period of report May 12, 2026 and was filed May 14, 2026; no late-filing flag indicated.

Context These transactions are compensation grants (awards), not open-market purchases or sales. The Deferred Settlement RSUs give Heyer an economic right to shares that will be delivered upon separation from service, while the 130,000-share option award vests over time (by May 12, 2027 or prior to the 2027 annual meeting) assuming continued service. Such awards are common for directors and do not by themselves indicate buying or selling sentiment.